CaNCURE Co-op Showcase

dsc_9827dsc_9836-1The CaNCURE Team would like to send out a congratulations to the 8 trainees who completed their CaNCURE co-op this December! We were so proud to see all your accomplishments at our second annual CaNCURE Co-op Showcase and to learn that for many of you, this co-op was a career-defining experience!

 

 


 

Upcoming Events

Innovation and Design of Medical Devices

Wednesday, March 29, 2017

Justin Chickles, CEO, Mobile Sense Technologies

121 Snell Library -- NEU, 4:00 PM


Mentor Spotlight


Michail Sitkovsky, Ph.D.

Professor and Chair of Immunophysiology and Pharmaceutical Biotechnology, NEU

A nanotechnology-based approach has been developed by this group to deliver co-adjuvants in a novel immunotherapy of cancer. Students will study how anti-tumor CD8 T-cells, modified with polymeric nanoparticles containing the A2A receptor antagonist and/or T cell-activating cytokine, increase local concentration of drugs in the tumor micro-environment.


Jeffrey M Karp, Ph.D.

Associate Professor of Medicine, HMS, BWH

The Karp lab has developed biocompatible polymer-based biomaterials with strongly adhesive nano-texture that have the ability to conform to irregular-shaped surfaces. Students will study self-assembled hydrogels loaded with pro-drug as a controlled delivery system for treatment of brain tumors.


Trainee Spotlight


John Berrigan

Health Science, '18

Use of a Triblock Copolymer Hydrogel for Controlled Release of Cisplatin and BMN-673

Chris Li

Health Science, '18

The Assessment and Comparison of Ferumoxtran as Contrast Imaging Agent in Patients with Pancreatic Cancers.

Brian Cortese

Biochemistry, '19

Development of PSMA-targeting nanoparticles for positron emitting tomography imaging in prostate cancer using animal models


Going on in the lab right now...